FMT
PCRX icon

First Mercantile Trust’s Pacira BioSciences PCRX Stock Holding History

First Mercantile Trust’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$233K Sell
4,159
-285
-6% -$16.4K 0.03% 363
2021
Q2 		$270K Sell
4,444
-246
-5% -$15.6K 0.03% 320
2021
Q1 		$329K Sell
4,690
-1,835
-28% -$131K 0.04% 268
2020
Q4 		$390K Sell
6,525
-522
-7% -$30.6K 0.04% 233
2020
Q3 		$404K Sell
7,047
-273
-4% -$15.9K 0.05% 208
2020
Q2 		$384K Buy
7,320
+1,101
+18% +$46K 0.05% 223
2020
Q1 		$209K Sell
6,219
-994
-14% -$41.3K 0.03% 328
2019
Q4 		$327K Sell
7,213
-173
-2% -$7.35K 0.04% 317
2019
Q3 		$281K Buy
7,386
+2,923
+65% +$117K 0.03% 377
2019
Q2 		$194K Buy
4,463
+728
+19% +$30.9K 0.02% 454
2019
Q1 		$142K Buy
+3,735
New +$146K 0.03% 566
2016
Q2 		– Sell
-9,303
Closed -$493K – 910
2016
Q1 		$493K Sell
9,303
-1,000
-10% -$58.5K 0.06% 382
2015
Q4 		$791K Buy
+10,303
New +$583K 0.08% 307
2015
Q1 		– Sell
-4,463
Closed -$395K – 1115
2014
Q4 		$395K Sell
4,463
-10,845
-71% -$1.03M 0.03% 566
2014
Q3 		$1.48M Sell
15,308
-3,980
-21% -$387K 0.12% 212
2014
Q2 		$1.77M Buy
19,288
+4,538
+31% +$346K 0.14% 188
2014
Q1 		$1.03M Buy
14,750
+6,850
+87% +$466K 0.08% 358
2013
Q4 		$454K Sell
7,900
-300
-4% -$15.8K 0.04% 586
2013
Q3 		$394K Buy
+8,200
New +$299K 0.03% 613

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

First Mercantile Trust's PCRX Position: Q3 2021 in Review

First Mercantile Trust reduced its Pacira BioSciences (PCRX) stake by 6.4% in Q3 2021, selling an estimated $16.4K and leaving 4,159 shares worth $233K. The position accounts for 0.03% of the portfolio, ranked #363.

First Mercantile Trust first reported a position in PCRX in Q3 2013 and has held it in 19 quarters since. The position peaked at $1.77M in Q2 2014. 259 funds tracked by Wall St. Rank hold PCRX as of Q3 2021.

  • First Mercantile Trust held 4,159 shares of Pacira BioSciences worth $233K as of Q3 2021.
  • First Mercantile Trust sold 285 Pacira BioSciences shares in Q3 2021, an estimated $16.4K.
  • Pacira BioSciences made up 0.03% of First Mercantile Trust's portfolio in Q3 2021, its #363 holding.
  • First Mercantile Trust first reported a position in Pacira BioSciences in Q3 2013 and has held it in 19 quarters since.
  • First Mercantile Trust's Pacira BioSciences position peaked at $1.77M in Q2 2014.
  • 259 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.